Health
Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates – Yahoo Finance
Moderna announces first participants dosed in study evaluating COVID-19 booster vaccine candidates.
Study to enroll 60 participants previously vaccinated with mRNA-1273 in Phase 2, to evaluate booster vaccine candidates against the B.1.351 variant first identified in South Africa
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants have been dosed with the Companys modified COVID-19 vaccines, designed to address the potential need for booster vaccine candidates, in an amendment to the ongoing…
-
Noosa News23 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General23 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News24 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
Noosa News24 hours agoIKEA and Tekla Are Launching a Whimsical New Collection